Results of subgroup analyses on GSTT1 null gene and GSTM1-GSTT1 dual null gene indicate that geographical location (China mainland, but not in Taiwan region), case numbers (≥100, but not <100) and source of controls are also significantly associated with HCC risk. This evidence concerns the gene GSTM1 and hepatocellular carcinoma.